Radical perineal prostatectomy: Oncological outcome during a 20-year period

Journal of Urology

Volumn 161, Issue 1, 1999, Pages 163-168

  Iselin, Christophe E ^a   Robertson, Judith E ^a   Paulson, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0032831224     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62088-3     Document Type: Article

References (16)

1. Cantrell, B. B., DeKlerk, D. P., Eggleston, J. C., Boitnott, J. K. and Walsh, P. C.: Pathological factors that influence prognosis in stage A prostate cancer: the influence of extent versus grade. J. Urol., 125: 516, 1981.
2. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
3. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, chapt. 10, pp. 171-198, 1977.
4. Murphy, G. P. and Whitmore, W. F.: A report of the workshops on the current status of the histopathologic grading of prostate cancer. Cancer, 44: 1490, 1979.
5. Gleason, D. F.: Histologic grading of prostate cancer: a perspective. Hum. Path., 23: 273, 1992.
6. Grayhack, J. T. and Assimos, D. G.: Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate, 4: 13, 1983.
7. Paulson, D. F.: Impact of radical prostatectomy in the management of clinically localized disease. J. Urol., 152: 1826, 1994.
8. Pound, P. R., Partin, A. W., Epstein, J. and Walsh, P. C.: Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol. Clin. N. Amer., 20: 395, 1997.
9. Coetzee, L. J., Layfield, L. J., Hars, V. and Paulson, D. F.: Proliferative index determination on prostatic carcinoma tissue, any additional prognostic value above Gleason score, ploidy and pathological stage? J. Urol., 157: 214, 1997.
10. Norberg, M., Holmberg, L., Wheeler, T. and Magnusson, A.: Five years follow-up after radical prostatectomy for localized prostate cancer - a study of the impact of different tumor variables on progression. Scand. J. Urol. Nephrol., 28: 391, 1994.
11. Lerner, S. E., Blute, M. L., Bergstralh, E. J., Bostwick, D. G., Eickholt, J. T. and Zincke, H.: Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J. Urol., 156: 137, 1996.
12. Epstein, J. I., Carmichael, M., Partin, A. W. and Walsh, P. C.: Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J. Urol., 149: 1478, 1993.
13. Partin, A. W., Piantadosi, S., Sanda, M. G., Epstein, J. I., Marshall, F. F., Mohler, J. L., Brendler, C. B., Walsh, P. C. and Simons, J. W.: Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology, 45: 831, 1995.
14. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. and Scardino, P. T.: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J. Urol., 152: 1843, 1994.
15. Zincke, H., Oesterling, J. E., Blute, M. L., Bergstrahl, E. J., Myers, R. P. and Barrett, D. M.: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J. Urol., 152: 1850, 1994.
16. Ohori, M., Wheeler, T. M., Rattan, M. W., Gotto, Y. and Scardino, P. T.: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J. Urol., 154: 1818, 1995.